Schizophrenia Resources – Supporter

Overview

You may be supporting a partner, parent, adult child, sibling or close friend who experiences schizophrenia. You probably know much more about their personality, interests and daily life than any clinician does. This page explains what current biological research tells us about schizophrenia, what kinds of support have been tested, and how to look after your own life and relationships alongside theirs.

Schizophrenia involves differences in the way the brain develops, processes information and coordinates perception, attention, motivation and thought. Someone close to you might hear voices, make connections between events that you do not see, struggle to concentrate, or need much more mental energy for ordinary tasks. Their experiences may vary from day to day. You might be helping with practical arrangements during a difficult period and barely think about the condition when things are going well.

Genomic research has identified hundreds of DNA regions associated with schizophrenia, including genes involved in the formation and signalling of connections between nerve cells. Recent studies have extended these findings across more diverse populations. The inherited contribution is substantial, but the biology differs between individuals; sleep, physical health, medicines and everyday circumstances can affect how that biology is expressed (Bigdeli et al., Nature, 2026).

The useful question for you is often quite practical: What helps this particular person think clearly, feel comfortable, pursue their interests and manage difficult periods? You can share observations, help them access evidence-based options, and contribute to decisions when they want your involvement. You are also a partner, relative or friend with needs, interests, work and relationships of your own.

On this page: Early warning signs · How to get diagnosed? · Life trajectory · Things you might need to work on · Workplace success · Family dynamics · Friendship & social skills · Intimate relationships · Self-help & coping · How it can be for Them to interact with You · Learn more (the Science) · Organisations · Resources · Other people like you

Early warning signs

If you know someone well, you may notice changes before they mention them. The most useful signs are usually changes from their own usual pattern, rather than behaviours you happen to find unfamiliar.

• Sleep: staying awake much later, sleeping very little for several nights, or reversing day and night.
• Attention and everyday organisation: finding it harder to follow a conversation, remember arrangements, complete familiar tasks or keep up with work or study.
• Perception and interpretation: voices becoming more intrusive, ordinary events taking on unusual importance, or increasing distress about being watched or threatened.
• Mood and energy: growing agitation, withdrawal, exhaustion, anxiety, or a marked change in how much company they want.
• Daily functioning: eating irregularly, missing appointments, neglecting important bills, or stopping activities they normally enjoy.

These changes can also have other causes, including stress, sleep loss, physical conditions, substances and medication effects. A 2024 review of early-warning research found that signs such as disturbed sleep, changes in mood and suspiciousness can help predict a returning episode, but their accuracy is imperfect. Paying attention to a few meaningful changes is more useful than scrutinising every unusual remark (Gleeson et al., Clinical Psychology Review, 2024).

When things are settled, ask what they tend to notice first. Perhaps sleep changes before anything else, or conversation becomes difficult to follow in a distinctive way. Work out what that pattern looks like together, give it a name, and agree how to signal it. A discreet hand gesture or an entirely unrelated word, such as “apples”, can communicate a great deal without a long explanation. The message might be: “Your speech is becoming hard for me to follow in the particular way we’ve noticed before an episode. This may be an early sign.” You can agree whether the next step is to leave a social situation, talk privately, get some sleep or seek further help.

If a change is substantial, be direct: “You’ve hardly slept for three nights, and you seem much more distressed. I think we should contact the team today.” If they are severely confused, in immediate danger, or unable to meet essential needs, seek urgent professional help. A shared plan made during a settled period can make these decisions clearer.

How to get diagnosed?

What are the symptoms of schizophrenia? Schizophrenia is a condition involving changes in perception, thought, information processing, motivation and behaviour. The defining features usually involve one or more periods of psychosis—when a person’s perceptions or strongly held interpretations differ markedly from what others can verify. The symptoms are commonly grouped into several areas:

• Hallucinations: hearing voices, sounds or other sensations without an identifiable external source. Hearing voices is particularly common. Voices may comment on what the person is doing, speak directly to them, or be distressing and difficult to ignore.
• Delusions: firmly held beliefs that remain convincing to the person despite strong evidence against them. Examples include believing that others are monitoring them, that unrelated messages are directed personally at them, or that outside forces can influence their thoughts or actions.
• Disorganised thinking and speech: difficulty keeping a line of thought, connections between ideas that other people cannot follow, or answers that move unexpectedly between topics. When marked, conversation can become difficult even with someone who knows the person well.
• Changes in motivation, expression and engagement: reduced drive to begin activities, less speech or facial expression, diminished interest or pleasure, and withdrawal from social contact. Researchers call these negative symptoms, meaning a reduction in functions that were previously present—not a judgement about the person.
• Cognitive difficulties: changes in concentration, working memory, processing speed, planning and problem-solving. These may affect studying, work, finances and daily organisation even when hallucinations or delusions have become less intrusive.
• Changes in movement or behaviour: in some episodes, marked agitation, unusual postures or greatly reduced movement and responsiveness. Severe movement changes need prompt clinical assessment.

The combination and intensity vary. Someone may mainly experience voices and unusual beliefs; another person may have prominent difficulties with motivation and thinking. Symptoms also change during and between episodes. These categories are part of the internationally recognised clinical description of schizophrenia (World Health Organization, Schizophrenia, 2026).

How is schizophrenia diagnosed? A clinician assesses whether characteristic symptoms have persisted for an appropriate period, how they affect everyday life and whether another explanation is more likely. Hearing a voice on one occasion or having an unusual belief alone does not establish schizophrenia. Bipolar disorder with psychosis, severe depression with psychosis, substance-related experiences, neurological illness, medication effects and some physical conditions can produce overlapping symptoms. An assessment may therefore include a medical examination and selected tests to investigate these alternatives.

There is not yet a single blood test, genetic test or brain scan that reliably establishes schizophrenia in an individual. If you are invited to contribute, describe concrete changes you have observed—for example, when voices first appeared, whether conversation became difficult to follow, or how concentration and daily activities changed. Your observations can help establish the time course, while the person being assessed remains central to the conversation and decisions.

Personalised prescribing is already beginning to produce useful results. Some DNA variants affect how the body processes medicines. In a randomised trial involving 210 patients, about 82% of those whose treatment was guided by genetic information responded after six weeks, compared with about 65% receiving usual prescribing. This is evidence for a particular genetic-guided approach, not a guarantee that every commercial test can select the best medicine (Kang et al., JAMA Network Open, 2023).

If someone is having difficult side effects or repeated unsuccessful medication trials, you can suggest asking the prescriber whether a relevant pharmacogenetic test or specialist review is available. If the person wants to talk to the clinician alone, they can. You can still ask for general information about how best to support them.

Life trajectory

Can someone with schizophrenia get better? Yes. Hallucinations, delusions and disorganised thinking can improve substantially with treatment, and some people achieve prolonged remission or clinical recovery. Others experience repeated episodes, persistent symptoms or difficulties with thinking, motivation and everyday functioning. The course varies considerably, and the first episode does not tell you exactly what the rest of someone’s life will be like.

A 2024 study followed 102 people with first-episode schizophrenia-spectrum psychosis for ten years. At follow-up, 29% met the study’s criteria for clinical recovery, 31% had treatment-resistant illness, and the remaining 40% had a mixture of partial improvement and periods of remission and relapse. These are results from one cohort, not a prediction for the person you support. They do, however, show both that substantial recovery is possible and that persistent difficulties are common (Wold et al., Schizophrenia, 2024).

A larger 2026 study tracked 376 people with first-episode schizophrenia-spectrum psychosis over 20 years. It found 21% with sustained high functioning, 37% with moderate improvement followed by some decline, and 42% with ongoing major functional difficulties. These categories describe everyday functioning rather than the clinical-recovery definition in the ten-year study. Taken together, the studies show why prognosis should cover both symptoms and the ability to manage work, relationships and independent living (Abella et al., Schizophrenia Bulletin, 2026).

What can remain difficult when psychosis improves? Voices or delusions may become much less intrusive while working memory, concentration, motivation or mental energy remain affected. For some people, these difficulties have a greater impact on employment, study and relationships than the symptoms most visible during an acute episode. Medication can reduce psychotic symptoms but may also cause sedation, movement changes or other unwanted effects. Treatment therefore needs to assess cognitive and everyday functioning alongside symptom improvement.

Does schizophrenia shorten life expectancy? Yes, substantially at a population level. Studies from different countries and periods have reported average reductions of approximately 10–20 years. A large systematic review estimated 15.4 years of potential life lost for schizophrenia-spectrum conditions. These figures describe population outcomes and cannot be used to calculate how long one particular person will live (Chan et al., eClinicalMedicine, 2023).

Why is mortality higher? Premature deaths are not explained simply by psychiatric symptoms. Important causes include cardiovascular disease, diabetes and other metabolic conditions, respiratory and infectious illnesses, cancer, suicide and accidents. Some medicines increase metabolic risk, while difficulties obtaining timely medical care, recognising physical illness and accessing appropriate treatment also contribute. In a 2025 Lithuanian study following 7,883 people hospitalised with schizophrenia, the observed death rate was almost twice that expected from national rates, and circulatory-system diseases were a particularly important cause. Because it studied people who had been hospitalised, its estimate may not represent everyone with schizophrenia (Drevinskaite et al., Schizophrenia, 2025).

This mortality gap makes comprehensive healthcare an essential part of support. Heart disease, high blood pressure, diabetes, respiratory symptoms, infections and cancers need the same timely investigation and evidence-based treatment as they would for anyone else. Medication reviews should include their effects on weight, glucose, cholesterol, movement, sleep and sexual function. The person you support should be able to access appropriate primary care, screening and specialist treatment—not have physical symptoms automatically attributed to schizophrenia.

There are ways to improve specific risks. In the 2025 Danish HISTORI trial, semaglutide improved blood glucose and weight in people receiving antipsychotic treatment who had prediabetes and overweight or obesity, although it did not improve schizophrenia symptoms (Ganeshalingam et al., JAMA Psychiatry, 2025). This is one example of treating a measurable physical-health problem directly.

As a partner, relative or friend, you may help someone recognise a change, discuss treatment effects or obtain timely care. You should not have to shoulder the responsibility for preventing medical complications alone. Reliable follow-up, appropriate physical healthcare and access to treatments that genuinely improve symptoms and functioning are responsibilities of the healthcare system too.

Things you might need to work on

Good support is often a set of small, agreed practical actions. You do not need to become an expert at judging someone else’s thoughts. You do need to know how you both communicate, where you can help, and where another person or service would be more useful.

Learn their individual pattern. Find out what an ordinary day looks like for them and what changes when they are becoming unwell. Ask which observations they find helpful and which feel intrusive. If they want to track sleep, medication effects or cognition, you can help make that easy without turning your relationship into constant monitoring.

Help with tasks they actually want help with. A lift to an appointment, an extra pair of hands with paperwork, a quieter place to work or a reminder about an agreed task may be more useful than frequent questions. Some difficulties in working memory and planning can improve through structured cognitive remediation. A 2024 analysis of 67 randomised trials involving 5,334 participants found lasting, though on average modest, improvements in cognition and everyday functioning. The gains were more useful when people had opportunities to apply new skills in real life (Vita et al., American Journal of Psychiatry, 2024).

Be straightforward when you are concerned. “Are you okay?” and “I think we should get some help today” can be entirely appropriate between people who know each other. Explain what has changed and why you are concerned. Avoid lengthy debates about a perception or belief that neither of you can resolve in the moment.

Keep treatment side effects on the agenda. If someone is sleeping twelve hours a day, has developed restlessness, movement difficulties, weight changes or reduced libido, those effects deserve attention. You can help them record what changed and encourage a review. Decisions about changing or stopping prescribed medication should be made with the prescriber, with a plan for follow-up.

Practise things together only if you both enjoy the arrangement. Cooking, handling a journey, preparing for a conversation, taking a class or trying a new activity can build confidence in ordinary ways. The aim is for the person to do more of what they want, with less help where possible.

Work out what is yours to do. You can care deeply about somebody without being their only source of support, their unpaid case manager, or the person who fixes every difficult day. Your own time, work, sleep and friendships need attention too.

Workplace success

The scale of the employment problem is considerable. In a 2026 Spanish register study of 139,594 working-age adults with schizophrenia, only 15.2% were employed in 2023, compared with 62.5% of adults with other recorded diagnoses; 49.3% of the schizophrenia group received disability pensions. These are Spanish figures, shaped partly by national employment and benefit systems, but they demonstrate how much harder access to paid work can be (Llorca-Bofí et al., European Archives of Psychiatry and Clinical Neuroscience, 2026).

If the person you support wants to work, study or return to a previous role, help them think about the conditions in which they function best. Concentration, working memory, sensory demands and fatigue can matter as much as the job description itself.

They might benefit from written priorities, fewer interruptions, flexible hours, a gradual return or reliable transport. Ask what they want you to do: help compare courses, practise an interview, talk through the commute or simply celebrate an achievement. Avoid becoming the person who checks their performance unless they have explicitly asked for that.

Individual Placement and Support (IPS) is a tested approach that helps people pursue real jobs or education with individualised assistance. In a 2025 randomised trial of young adults with early psychosis, 78% of those offered the programme achieved work, education or training of at least 15 hours a week at some point during follow-up, compared with 55% receiving standard care (Jäckel et al., Brain and Behavior, 2025).

Your career matters equally. If appointments, night-time interruptions or care tasks are affecting your work, consider whether other relatives, community services or professionals can share them. Reshaping the support arrangement may benefit both of you.

Family dynamics

Families bring different histories and expectations to a relationship. A parent may remember what their adult child was like at school; a partner knows how they manage an ordinary evening; a sibling or long-term friend may notice a subtle change that others miss. These perspectives can be useful when offered with care and with the person’s agreement.

The family environment can also be made easier for everyone. Researchers have studied structured family education and support, including how relatives communicate and solve practical problems together. A 2024 Cochrane review of 26 randomised trials found that these interventions probably reduce the burden on family supporters in the short term. They may also reduce relapse, although confidence in that result was lower. The evidence is less clear for medication adherence and other long-term outcomes (Chien et al., Cochrane Database of Systematic Reviews, 2024).

If you are a partner

You may share a home, money, parenting, social life and plans for the future. Discuss which responsibilities each of you is comfortable carrying, and revisit the arrangement when energy or health changes. Keep some time together that has nothing to do with schizophrenia—food, music, friends, holidays or whatever brought you together.

If you are a parent

Supporting an adult son or daughter often involves finding a balance between being available and stepping back. Ask which practical tasks they want assistance with, respect privacy around healthcare and relationships, and make plans for support beyond yourself. If the person is still a child or adolescent, age-appropriate parental responsibilities and safeguarding needs also apply.

If you are an adult child, sibling or friend

You may be close without living together. Decide what contact and practical help you can reliably offer. It is useful to know whom to contact in a genuine crisis, but you need not be available at every hour. A broader network is less fragile than depending on one person.

Friendship & social skills

Social connection can be a substantial challenge. A 2025 systematic review estimated that 63% of people with schizophrenia or schizophrenia-spectrum conditions experienced objective social isolation. That measures limited social contact or networks, rather than assuming that spending time alone is itself a problem. It helps explain why creating opportunities for friendship can be at least as important as discussing symptoms (Hajek et al., Epidemiology and Psychiatric Sciences, 2025).

If someone becomes quieter or turns down invitations, there may be several explanations: fatigue, medication effects, concentration demands, distressing voices, or simply wanting time alone. Ask them what kind of company they enjoy rather than assuming they need to socialise more.

You can make social occasions easier by checking whether they prefer small groups, quieter places or an easy way to leave. A private signal is particularly valuable here. If one of you notices a familiar change in how a conversation is going, an agreed gesture or code word can identify it immediately, without drawing attention from other people or starting an argument in public.

Friendship does not have to become a project. Walks, films, gaming, shared interests and ordinary messages may offer more connection than formally scheduled conversations about wellbeing. If they want help understanding a confusing social situation, listen first and offer your perspective directly. It is perfectly possible to disagree about something while remaining close.

Some people want structured work on interpreting social situations and communicating more comfortably. Social-cognition programmes are being studied for this purpose; a small 2025 randomised trial of an individualised programme reported improvements in several social and functional measures, although larger trials are needed to confirm how well those gains transfer to daily life (SoCIAL trial, 2025).

Intimate relationships

Sex and intimacy deserve frank discussion. This section is especially relevant if the person you support is your partner, but parents and friends may also be asked for advice about relationships, dating, sexual health or treatment side effects.

Establishing and maintaining a romantic relationship can be difficult when mental energy, symptoms, medication effects and opportunities to meet people all influence daily life. A review of long-term outcomes after a first episode of psychosis reported that approximately 21% of participants were in a romantic relationship at an average follow-up of eight years. That research includes several psychosis diagnoses, so it is not a schizophrenia-only estimate. It does show that romantic connection needs to be considered as a real-life outcome of care (Ajnakina et al., Schizophrenia Research, 2021).

If the person you support is your partner

You might be enjoying a close and satisfying relationship. You might also notice changes in desire, touch, arousal or the amount of energy either of you has for sex. A period of psychosis, disrupted sleep, depression, some physical-health conditions and certain medicines can affect sexual functioning.

Research confirms that sexual difficulties are common enough to ask about routinely. A 2023 analysis of 72 studies involving more than 21,000 people with schizophrenia estimated that about 56% had some form of sexual dysfunction, although rates varied considerably between studies. Problems included low desire, difficulty with erections or orgasm, and menstrual changes. The findings cannot tell you what is causing a problem in your particular relationship (Korchia et al., JAMA Psychiatry, 2023).

Some medicines raise the hormone prolactin, which can influence libido, arousal, menstrual cycles and sexual function. Others may cause tiredness or emotional flattening. If your partner’s desire has changed noticeably after starting or adjusting a medicine, encourage them to tell their prescriber. A review may include checking prolactin and other relevant health factors, or considering a medication adjustment. Changing treatment needs a careful discussion of benefits and risks; abruptly stopping it can cause problems.

Your own desire may have changed too. When sleep is interrupted, household responsibilities increase or you spend a lot of energy worrying, sex may be the last thing you feel like doing. In a small 2026 case-control study, spouses of people with schizophrenia reported more sexual difficulties than spouses in the comparison group. This study cannot establish what caused the differences, but it adds evidence that the supporting partner’s sexual wellbeing should also be discussed (Prajapati et al., Industrial Psychiatry Journal, 2026).

Talk about what each of you misses or wants without turning it into a test of love. You might both want more sex, or one of you might want less, or you might want to rebuild closeness after a difficult period. Sometimes the most useful change is treating a side effect; sometimes it is redistributing responsibilities or getting several nights of proper sleep. Kissing, touch, sleeping close, dates and time together can remain important whether or not you have sex. Neither person owes the other sexual contact.

Consent and mutuality. A schizophrenia diagnosis does not determine someone’s ability to consent. What matters, as in any relationship, is whether each person is able to understand what is happening, freely wants it, can communicate their wishes and can change their mind. During a period of severe confusion, intense fear, markedly altered judgement or heavy sedation, it may be unclear whether meaningful consent is possible. In that situation, pause sexual activity and return to the conversation when both of you are comfortable and able to decide. The same standard applies to your own willingness and wellbeing. Decisions about capacity in healthcare are recognised as specific to the person, decision and time—not something established by a diagnostic label (Morena et al., Medicina, 2024).

You may disagree about money, children, living arrangements or sex while someone is unwell. Where possible, postpone major irreversible decisions until you can both discuss them clearly. If the relationship remains unhappy or incompatible even when things are settled, you can take that seriously. You are not required to continue a romantic or sexual relationship because you have been providing support.

If you are a parent, sibling or friend

The person you support may ask about dating, contraception, fertility, sexual side effects or whether to disclose their diagnosis to a partner. Offer factual information, listen to what they want, and help find a suitable clinician or sexual-health service if invited. Adults may want a private consultation, and their relationship decisions remain theirs.

If sexual interest or function changed after a prescription, encourage them to raise it as a medical issue rather than putting up with it indefinitely. You can help locate information or accompany them to an appointment if they wish. If you are supporting a younger person, make sure advice is age appropriate and that concerns about exploitation or safety are addressed.

Self-help & coping

Your own physical and emotional health affects how much you can offer, but you also need a life that is satisfying on its own terms. Think about support as something that should be sustainable, shared and adjustable.

Protect your sleep and regular life. Try to keep dependable time for work, friends, exercise, hobbies and privacy. If a difficult period is disrupting your nights, arrange who can take calls, attend appointments or stay nearby. You do not have to be the sole person awake, worried and responsible.

Use the help available to you. Family education, communication training, peer groups, counselling for yourself and practical respite can make caring less exhausting. In a 2026 randomised trial with 72 caregivers initially assigned, an eight-week communication-focused programme improved several measures of caregiver wellbeing compared with usual care; its results were based on a relatively small group and do not establish one ideal phrase or script (Harkın & Bilgin, BMC Psychiatry, 2026).

Agree on how to handle a difficult period. When the person is well, discuss their usual warning signs, whom they want contacted, what has helped before, and what kinds of intervention they would prefer or avoid. A written advance plan can include medication experiences, trusted contacts, practical responsibilities and personal preferences. In a 2022 randomised trial involving people with several serious psychiatric conditions, peer-supported psychiatric advance directives reduced compulsory admissions over the following year (27% versus 40%). Results came from a specific intervention and service context, but they show the value of taking people’s treatment preferences seriously before a crisis (Tinland et al., JAMA Psychiatry, 2022).

Watch your own wellbeing. If you are becoming irritable, isolated, physically unwell, anxious, depressed or unable to concentrate at work, your current arrangement may need to change. You can speak to a professional on your own behalf without disclosing every private detail of the other person’s life.

When to reduce, stop or leave a caring role

Care arrangements can become unhealthy even when two people love one another. Consider changing the arrangement when it repeatedly damages your sleep, health, work, finances, friendships or relationship, or when you have become the only person responsible for needs that require several people or professional services.

• First, see what can be shared or changed. Ask relatives, community services or the clinical team to take on clearly defined tasks. Consider respite, different living arrangements or fewer responsibilities.
• Set limits you can actually maintain. You might be able to visit twice a week but not provide daily transport, or help arrange care without living together. State those limits plainly.
• You may decide to stop being the main supporter. If the arrangement remains harmful or you simply cannot sustain it, stepping back is a reasonable decision. A romantic relationship can end, or a family relationship can continue with a much smaller practical role.
• Arrange a safe handover where someone depends on you for essentials. If the person cannot currently obtain food, shelter, medication or urgent care without help, involve an appropriate service or another responsible person before withdrawing from those particular tasks. Responsibilities differ if you are caring for a dependent child.
• Leave immediately if you are unsafe. Threats, coercion, violence or abuse require a safety response, whatever anyone’s diagnosis. Contact local emergency services or a domestic-abuse support service if needed. You do not need to remain in danger to demonstrate care.

These are decisions about your circumstances and boundaries, not predictions based on schizophrenia. You can respect someone, want good things for them, and still decide that your life or relationship needs to change.

How it can be for Them to interact with You

The best starting point is the relationship you already have. You probably know whether the person likes blunt honesty, humour, space to think, affectionate teasing or a quiet conversation over coffee. Communication advice is useful when it helps you understand each other; it becomes awkward when you start speaking as though you are conducting a clinical interview.

Research supports teaching supporters skills such as listening, asking open questions, avoiding repetitive arguments and sharing concerns without unnecessary criticism. In a small 2022 randomised trial, a brief programme called Motivational Interviewing for Loved Ones reduced family conflict and critical or overinvolved communication compared with a waiting-list group. It did not show an improvement in treatment adherence. The intervention aims to improve conversations between people who care about each other, not turn relatives into therapists (Kline et al., Schizophrenia Research, 2022).

A private signal for a recognisable pattern

This is worth developing properly together. Suppose you have noticed a recurring change in how the person speaks: their thoughts start jumping between subjects, sentences become difficult to follow, and you recognise the pattern from an earlier period when psychosis developed. Trying to explain all this in front of friends could be embarrassing for both of you and may lead to a pointless debate. One small gesture can communicate the whole observation.

Start by talking, at a settled time, about the actual pattern. Describe two or three concrete examples and ask whether the person recognises it too. Agree what the gesture or code word means—perhaps “I can’t follow what you’re saying now, and this looks like the pattern we identified together”. Choose something private and ordinary: touching your watch, moving a ring, or saying “apples”. Then decide what happens when either of you uses it. You might step outside, leave an event, compare what each of you has noticed, or contact a trusted professional if the change is substantial.

The real value is recognition, shared meaning and discretion. Both of you know what the signal refers to, so neither has to find the right words in a tense moment. You can also revisit it later if one of you thinks the signal was mistaken. Research supports identifying individual early-warning patterns and learning less conflictual ways to communicate; the specific word or gesture is your own practical solution, rather than a separately trialled clinical intervention.

What does that mean in ordinary speech?

• Say what you have noticed. “You seem much more tired this week,” or “You haven’t slept much and I’m getting worried.” Specific observations are more useful than labels or vague hints.
• Ask a real question. “Are you feeling okay? What would you like to do?” is often enough. Listen to the answer, even if their priority differs from yours.
• Be direct when the situation calls for it. “You seem a lot worse today. I think we should go to psychiatry today.” You can explain what has changed, hear their view and, where possible, agree on the next step.
• Do not turn unusual perceptions into an argument. If the person is distressed about a voice or a perceived threat, deal with the distress and practical situation. You can describe your own perspective without repeatedly trying to prove theirs wrong.
• Use the shared signal when you recognise the agreed pattern. It lets you say something quite specific in seconds, without explaining the concern to everyone nearby. Follow through on the response you agreed together.
• Leave room for normal disagreement. A person can be tired, annoyed, wrong about something or simply eccentric without every difference becoming a mental-health issue. You can also be wrong about what you noticed.

A 2024 interview study of caregivers who completed communication training described less controlling exchanges and more confidence in speaking directly. That is a helpful direction: more honest, less exhausting conversations, with no need for artificial phrases (Ipekci et al., Early Intervention in Psychiatry, 2024).

Sometimes the person will not want to talk, and you can leave the conversation for later. Sometimes you will need to say that something affects you too: “I need to sleep tonight,” or “I can’t keep cancelling work.” Being close to someone includes room for both people’s views.

Learn more (the Science)

Genomics and developmental biology. Schizophrenia has a strong inherited component, with population-level heritability estimates commonly around 60–80%. In 2022, the Psychiatric Genomics Consortium analysed data from up to 76,755 people with schizophrenia and 243,649 controls. It identified 287 associated genomic regions and prioritised 120 genes, particularly those involved in neuronal development, synaptic structure and signalling. Many associated DNA variants are common and individually have small effects; the combined pattern matters. These are findings about population-level susceptibility, not a way of reading one person’s future from a genetic profile (Trubetskoy et al., Nature, 2022).

Rare variants and specific proteins. The SCHEMA consortium studied rare protein-disrupting genetic variants in 24,248 cases and 97,322 controls and implicated ten genes with substantial individual effects on susceptibility. Examples include GRIN2A and GRIA3, which encode components of glutamate receptors. Unlike a broad statistical association, a damaging variant in a protein-coding gene can provide a more direct starting point for understanding a molecular pathway. Such rare variants explain only a minority of cases and do not represent a universal mechanism (Singh et al., Nature, 2022).

Why synapses matter. A synapse is a connection through which one nerve cell influences another. Glutamate generally increases the activity of receiving neurons; GABA helps regulate and inhibit activity. Dopamine influences learning, motivation and the importance assigned to signals. The genomic findings implicate how synapses form, how their receptors function, and how excitatory and inhibitory circuits are coordinated. Different combinations of disrupted signalling may contribute to apparently similar experiences. For you as a supporter, this helps explain why two people given the same diagnosis may have very different cognitive strengths, energy levels, perceptions and responses to treatment.

Multiomics and biological subtypes. Researchers increasingly combine DNA studies with transcriptomics (which genes are being expressed), proteomics (which proteins are present), and other molecular and brain measurements. A 2025 cross-ancestry integration of these data prioritised additional biological pathways and identified 61 previously unreported associated loci. These approaches help move from finding statistical associations toward identifying affected tissues, cells and molecular mechanisms (Dang et al., Nature Human Behaviour, 2025).

Biomarkers: promising findings and the need for independent testing. Researchers are studying blood-protein signatures, inflammatory measures, brain imaging, electrophysiology and digital changes in sleep or behaviour. A 2026 blood-protein study reported a prediction accuracy of AUC 0.81 in an independent group at clinical high risk of psychosis; a separate 2024 attempt to validate an earlier blood-protein predictor performed close to chance (C-statistic 0.51). An AUC or C-statistic measures how well a model ranks people with and without an outcome, not the probability that a particular person will develop it. These markers are still being developed and validated; they are not substitutes for clinical assessment (Chan et al., Translational Psychiatry, 2026; Byrne et al., Schizophrenia Bulletin, 2024).

Pharmacogenomics and medication metabolism. Variants in genes such as CYP2D6 and CYP2C19 influence the rate at which some drugs are metabolised. A genetically slower or faster metaboliser may experience different blood concentrations from the same dose. Other candidate markers attempt to predict efficacy or particular side effects. Results from randomised studies are encouraging for selected testing algorithms, but tests differ in which genes and medications they cover. A second randomised trial in 2024 involving 186 participants also suggested benefits from genetic guidance, although dropout limits certainty about its results (Qin et al., Journal of Psychiatric Research, 2024). If the person you support is interested, the clinician can explain whether any gene–drug relationship would actually affect a proposed prescription.

New pharmacological targets. Many established antipsychotics act at dopamine D2 receptors. Xanomeline–trospium instead acts principally through muscarinic acetylcholine M1/M4 receptor pathways. In the phase 3 EMERGENT-3 randomised study it improved schizophrenia symptom ratings over five weeks compared with placebo, with gastrointestinal side effects among the main tolerability issues. It demonstrates that treating psychosis need not depend on direct D2 receptor blockade, although this treatment is not yet matched to a person’s genome or biomarker profile (EMERGENT-3, JAMA Psychiatry, 2024).

Training and targeted therapies. Beyond medicines, cognitive remediation can exercise attention, working memory and problem solving, while social-cognition interventions work on interpreting social information. For distressing voices, the AVATAR2 trial used guided interaction with a digital representation of a voice; it found less voice-related distress at 16 weeks, but the principal improvement was not clearly sustained at 28 weeks. These approaches can be discussed in terms of the person’s actual goals and the outcomes demonstrated in trials (AVATAR2, Nature Medicine, 2024).

How to judge a precision-medicine claim. Ask what a test measures, whether it has been validated in independent populations, and whether treatment based on its result has improved outcomes in controlled studies. For a new intervention, ask which specific problem it is expected to improve—voices, cognition, weight, sleep, social functioning, employment or something else. A strong genomic association, a useful laboratory biomarker and a proven clinical decision tool are different stages of evidence.

Organisations

• National Hearing Voices Network — peer-led information and groups for people who hear voices or have unusual perceptions; supporters may also find useful perspectives.
• Intervoice — directory of international hearing-voices networks.
• International Society for Psychological and Social Approaches to Psychosis (ISPS) — research, education and collaboration on understanding psychosis and improving support.
• Rethink Mental Illness — information and practical support for family members and friends, including advice about finances, services and carers’ rights in England.
• WHO QualityRights — material on supported decision-making, dignity, autonomy and reducing coercive practices.
• University of Washington FACTS communication-skills training — freely accessible training material for supporters.

Availability of services varies by country. Look for local family-support networks, carer respite services, supported employment providers and clinicians who include trusted supporters when the person wants that involvement.

Resources

The following research gives you starting points for understanding biology, treatment, communication and relationships in greater depth.

• Genetics and biological pathways: large-scale genomic discovery, Nature, 2022; rare coding variants and glutamate receptors, Nature, 2022; multiomics integration, Nature Human Behaviour, 2025.
• Prognosis and lifespan: ten-year first-episode recovery outcomes, Schizophrenia, 2024; life expectancy and years lost meta-analysis, eClinicalMedicine, 2023; Lithuanian mortality cohort, Schizophrenia, 2025.
• Personalised care: genetic-guided prescribing trial, JAMA Network Open, 2023; muscarinic-receptor treatment, JAMA Psychiatry, 2024; cognitive remediation outcomes, American Journal of Psychiatry, 2024.
• Communication and family support: Motivational Interviewing for Loved Ones trial, 2022; family intervention review, 2024; caregiver communication-training trial, 2026.
• Intimacy and sexual health: sexual-functioning evidence, JAMA Psychiatry, 2023; sexual functioning among spouses, 2026; research on antipsychotics, prolactin and sexual function, 2025.
• Planning and everyday life: early-warning signs review, 2024; peer-assisted advance directives trial, 2022; supported employment and education trial, 2025.
• Work, friendships and partnerships: Spanish national employment register — 2026; social isolation meta-analysis — 2025; romantic relationships after first-episode psychosis — 2021.

You can also explore Relatix Health’s resources for the person’s particular combination of cognition, sleep, sensory experiences, motivation and social preferences, and Relatix Bio for research-facing work on biological mechanisms and evidence-based opportunities. Consider any opportunity on the basis of the methods, evidence and relevance to the person involved.

Other people like you

Supporters’ experiences vary as much as the relationships themselves. You may be a partner wondering about intimacy, a parent helping an adult child find independent support, a friend trying to understand unusual perceptions, or an adult child managing practical care for a parent. You may be doing several of these things at once.

It can help to hear from people who have found arrangements that work: how they share responsibility, stay close without constant monitoring, talk about medication side effects, retain a sex life, manage crises or decide to step back. Family and peer groups can also provide a place to discuss your own needs without expecting the person you support to meet every one of them.

We would like to hear what has genuinely helped. Which ways of communicating made things easier? What improved sleep, concentration, work, friendships or intimacy? What support did you need, and when did you realise a caring arrangement had to change? Practical experiences, alongside carefully evaluated research, can help other supporters make better-informed decisions.